State Street’s RAPT Therapeutics RAPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$152K Sell
19,062
-72,917
-79% -$583K ﹤0.01% 3892
2025
Q1
$898K Buy
91,979
+4,573
+5% +$44.6K ﹤0.01% 3455
2024
Q4
$1.1M Buy
87,406
+2,467
+3% +$31.2K ﹤0.01% 3469
2024
Q3
$1.37M Buy
84,939
+966
+1% +$15.5K ﹤0.01% 3425
2024
Q2
$2.05M Buy
83,973
+1,548
+2% +$37.8K ﹤0.01% 3311
2024
Q1
$5.92M Sell
82,425
-99,395
-55% -$7.14M ﹤0.01% 2860
2023
Q4
$36.1M Buy
181,820
+6,007
+3% +$1.19M ﹤0.01% 1879
2023
Q3
$23.4M Sell
175,813
-36,943
-17% -$4.91M ﹤0.01% 2068
2023
Q2
$31.8M Buy
212,756
+7,875
+4% +$1.18M ﹤0.01% 1948
2023
Q1
$30.1M Sell
204,881
-37,709
-16% -$5.54M ﹤0.01% 1968
2022
Q4
$38.4M Buy
242,590
+83,354
+52% +$13.2M ﹤0.01% 1818
2022
Q3
$30.7M Buy
159,236
+97,878
+160% +$18.8M ﹤0.01% 1932
2022
Q2
$8.96M Sell
61,358
-107,090
-64% -$15.6M ﹤0.01% 2794
2022
Q1
$29.6M Buy
168,448
+12,975
+8% +$2.28M ﹤0.01% 2118
2021
Q4
$45.7M Buy
155,473
+112,368
+261% +$33M ﹤0.01% 1869
2021
Q3
$10.7M Buy
43,105
+9,298
+28% +$2.31M ﹤0.01% 2855
2021
Q2
$8.6M Buy
33,807
+9,536
+39% +$2.43M ﹤0.01% 2991
2021
Q1
$4.31M Buy
24,271
+99
+0.4% +$17.6K ﹤0.01% 3110
2020
Q4
$3.82M Buy
24,172
+881
+4% +$139K ﹤0.01% 3099
2020
Q3
$6M Buy
23,291
+1,047
+5% +$270K ﹤0.01% 2693
2020
Q2
$5.16M Buy
22,244
+19,227
+637% +$4.46M ﹤0.01% 2742
2020
Q1
$513K Buy
3,017
+1,792
+146% +$305K ﹤0.01% 3446
2019
Q4
$271K Buy
+1,225
New +$271K ﹤0.01% 3600